Literature DB >> 24793692

How slow RNA polymerase II elongation favors alternative exon skipping.

Gwendal Dujardin1, Celina Lafaille2, Manuel de la Mata2, Luciano E Marasco2, Manuel J Muñoz2, Catherine Le Jossic-Corcos3, Laurent Corcos3, Alberto R Kornblihtt4.   

Abstract

Splicing is functionally coupled to transcription, linking the rate of RNA polymerase II (Pol II) elongation and the ability of splicing factors to recognize splice sites (ss) of various strengths. In most cases, slow Pol II elongation allows weak splice sites to be recognized, leading to higher inclusion of alternative exons. Using CFTR alternative exon 9 (E9) as a model, we show here that slowing down elongation can also cause exon skipping by promoting the recruitment of the negative factor ETR-3 onto the UG-repeat at E9 3' splice site, which displaces the constitutive splicing factor U2AF65 from the overlapping polypyrimidine tract. Weakening of E9 5' ss increases ETR-3 binding at the 3' ss and subsequent E9 skipping, whereas strengthening of the 5' ss usage has the opposite effect. This indicates that a delay in the cotranscriptional emergence of the 5' ss promotes ETR-3 recruitment and subsequent inhibition of E9 inclusion.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24793692     DOI: 10.1016/j.molcel.2014.03.044

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  90 in total

Review 1.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

2.  Defective histone supply causes changes in RNA polymerase II elongation rate and cotranscriptional pre-mRNA splicing.

Authors:  Silvia Jimeno-González; Laura Payán-Bravo; Ana M Muñoz-Cabello; Macarena Guijo; Gabriel Gutierrez; Félix Prado; José C Reyes
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

3.  TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing.

Authors:  Ryan J Marina; David Sturgill; Marc A Bailly; Morgan Thenoz; Garima Varma; Maria F Prigge; Kyster K Nanan; Sanjeev Shukla; Nazmul Haque; Shalini Oberdoerffer
Journal:  EMBO J       Date:  2015-12-28       Impact factor: 11.598

4.  Histone hyperacetylation and exon skipping: a calcium-mediated dynamic regulation in cardiomyocytes.

Authors:  Alok Sharma; Hieu Nguyen; Lu Cai; Hua Lou
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

Review 5.  Coupling of RNA Polymerase II Transcription Elongation with Pre-mRNA Splicing.

Authors:  Tassa Saldi; Michael A Cortazar; Ryan M Sheridan; David L Bentley
Journal:  J Mol Biol       Date:  2016-04-20       Impact factor: 5.469

6.  TINTIN, at the interface of chromatin, transcription elongation, and mRNA processing.

Authors:  Wajid Bhat; Salar Ahmad; Jacques Côté
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 7.  Nascent RNA and the Coordination of Splicing with Transcription.

Authors:  Karla M Neugebauer
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

Review 8.  Co-Transcriptional RNA Processing in Plants: Exploring from the Perspective of Polyadenylation.

Authors:  Jing Yang; Ying Cao; Ligeng Ma
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

9.  Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution.

Authors:  Andreas Mayer; Julia di Iulio; Seth Maleri; Umut Eser; Jeff Vierstra; Alex Reynolds; Richard Sandstrom; John A Stamatoyannopoulos; L Stirling Churchman
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

Review 10.  Non-coding transcript variants of protein-coding genes - what are they good for?

Authors:  Sonam Dhamija; Manoj B Menon
Journal:  RNA Biol       Date:  2018-09-10       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.